Literature DB >> 1993950

Community-acquired influenza C virus infection in children.

H Moriuchi1, N Katsushima, H Nishimura, K Nakamura, Y Numazaki.   

Abstract

To clarify the epidemiologic and clinical features of community-acquired influenza C infection in children, we took specimens throughout the year from a larger number of patients with acute respiratory illnesses in a pediatric clinic in Yamagata, Japan. During a 2-year survey, 20 strains of influenza C virus were isolated from 13,426 specimens. These isolates were recovered throughout the year. The ages of patients with influenza C virus isolates ranged from 2 months to 11 years and peaked at the age of 1 year. The clinical diagnosis of patients with influenza C virus infection included bronchitis in one child and pneumonia in four. Community-acquired influenza C infection in children can cause a variety of respiratory illnesses that cannot be clinically differentiated from those caused by other viruses.

Entities:  

Mesh:

Year:  1991        PMID: 1993950     DOI: 10.1016/s0022-3476(05)80489-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  Bacterial sinusitis and otitis media following influenza virus infection in ferrets.

Authors:  Ville T Peltola; Kelli L Boyd; Julie L McAuley; Jerold E Rehg; Jonathan A McCullers
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Antigenic and genetic characterization of influenza C viruses which caused two outbreaks in Yamagata City, Japan, in 1996 and 1998.

Authors:  Y Matsuzaki; K Sugawara; K Mizuta; E Tsuchiya; Y Muraki; S Hongo; H Suzuki; K Nakamura
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  A nationwide epidemic of influenza C virus infection in Japan in 2004.

Authors:  Yoko Matsuzaki; Chieko Abiko; Katsumi Mizuta; Kanetsu Sugawara; Emi Takashita; Yasushi Muraki; Hiroshi Suzuki; Masahide Mikawa; Shinichi Shimada; Katsuhiko Sato; Mitsutaka Kuzuya; Shinichi Takao; Kiyoko Wakatsuki; Tsutomu Itagaki; Seiji Hongo; Hidekazu Nishimura
Journal:  J Clin Microbiol       Date:  2007-01-10       Impact factor: 5.948

5.  Detection of influenza C virus in the United Kingdom.

Authors:  P Chakraverty; R S Matthews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

6.  Isolation and characterization of influenza C viruses in the Philippines and Japan.

Authors:  Takashi Odagiri; Yoko Matsuzaki; Michiko Okamoto; Akira Suzuki; Mariko Saito; Raita Tamaki; Socorro P Lupisan; Lydia T Sombrero; Seiji Hongo; Hitoshi Oshitani
Journal:  J Clin Microbiol       Date:  2014-12-31       Impact factor: 5.948

7.  Genetic Lineage and Reassortment of Influenza C Viruses Circulating between 1947 and 2014.

Authors:  Yoko Matsuzaki; Kanetsu Sugawara; Yuki Furuse; Yoshitaka Shimotai; Seiji Hongo; Hitoshi Oshitani; Katsumi Mizuta; Hidekazu Nishimura
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

8.  Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel.

Authors:  Musa Hindiyeh; Virginia Levy; Roberto Azar; Noemi Varsano; Liora Regev; Yael Shalev; Zehava Grossman; Ella Mendelson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

9.  Genetic and antigenic characteristics of a human influenza C virus clinical isolate.

Authors:  Runxia Liu; Zizhang Sheng; Tao Lin; Chithra Sreenivasan; Rongruan Gao; Milton Thomas; Julian Druce; Ben M Hause; Radhey S Kaushik; Feng Li; Dan Wang
Journal:  J Med Virol       Date:  2019-09-23       Impact factor: 2.327

10.  Frequent reassortment among influenza C viruses.

Authors:  Y Matsuzaki; K Mizuta; K Sugawara; E Tsuchiya; Y Muraki; S Hongo; H Suzuki; H Nishimura
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.